Health Unlimited acquires Strategen

An award-winning global healthcare communications and consultancy agency, Health Unlimited, recently announced that it completed an agreement to acquire a medical communications consultancy, Strategen. The statement follows at a time of heightened growth for Health Unlimited, expanding its pharmaceutical client portfolio and progressing offerings and programmes within its healthcare communications and medical education services.

Health Unlimited’s medical education services will be further strengthened through the acquisition, through the addition of Strategen’s twenty-five years of heritage in critical opinion development, pharmacoeconomics and publications, audits and research services.

Health Unlimited Managing Director, Clare Peck, stated: “Strategen’s decades-long legacy and expertise is a great complement to Health Unlimited, enhancing our medical education offer by adding more depth to publications, pharmacoeconomic support, audit development and meta-analysis. Combining our strengths adds important breadth to our capabilities in achieving even greater impact for our pharmaceutical and biotech clients in the years ahead. We are incredibly excited by this acquisition, and we welcome Strategen’s addition to Health Unlimited.”

Strategen Company Director, Denise Buchan, stated: “Strategen has a long reputation for delivering value-added medical communication and market access solutions for our clients. I am delighted that through the transfer of our clients and expertise to Health Unlimited – this will continue. With Health Unlimited’s larger and integrated in-house capabilities and same high level of client service, Strategen’s clients can expect continued best-in-class outputs and value.”